The Lancet Oncology Impact Factor, Indexing, Ranking

The Lancet Oncology (LO) is a scholarly journal dedicated to publishing research in the field of Medicine. Elsevier is the publisher of this esteemed journal. The P-ISSN assigned to The Lancet Oncology is 1470-2045 and its abbreviated form is Lancet Oncol.

The Lancet Oncology covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Topics include but are not limited to breast cancer; endocrine system cancer; gastrointestinal cancer; genitourinary cancer; gynaecological cancer; haematological cancer; head and neck cancer; neurooncology; paediatric oncology; thoracic oncology; sarcoma; skin cancer; epidemiology, cancer prevention, and cancer control; supportive care; imaging; and health-care systems.

The Lancet Oncology Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of The Lancet Oncology Journal is Lancet Oncol.

The Ranking of The Lancet Oncology in 2026 is 50. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Impact Factor of The Lancet Oncology in 2026 is 51.1. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The SCImago of The Lancet Oncology in 2026 is 12.270. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The H-Index of The Lancet Oncology in 2026 is 382. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Quartile of The Lancet Oncology is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The The Lancet Oncology is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. PubMed
• 5. Medline
• 6. Google Scholar

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of The Lancet Oncology is David Collingridge

The Lancet Oncology Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of The Lancet Oncology is 6,300 USD

The Lancet Oncology Call for paper : The Lancet Oncology invites original research contributions for consideration of publication in The Lancet Oncology journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in The Lancet Oncology involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Medicine.
• Familiarize Yourself: Read and understand the aims and scope of The Lancet Oncology to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the The Lancet Oncology guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago